copper tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine has been researched along with Leukemia L 1210 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dovinová, I; Hanusovská, E; Hunáková, L; Paulíková, H; Rauko, P; Tibenská, E | 1 |
Dovinová, I; Duracková, Z; Jantová, S; Labuda, J; Novotný, L; Urbancíková, M; Wsolová, L | 1 |
2 other study(ies) available for copper tetrabenzo(b,f,j,n)-1,5,9,13-tetraazacyclohexadecine and Leukemia L 1210
Article | Year |
---|---|
Main targets of tetraaza macrocyclic copper complex on L1210 murine leukemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Cell Membrane; Copper; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Glutathione; Leukemia L1210; Mice; Organometallic Compounds; Oxidative Stress; Tumor Cells, Cultured | 2002 |
Macrocyclic Cu(II)tetraanhydroaminobenzaldehyde complex--antiproliferative activity in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Benzaldehydes; Carcinoma, Hepatocellular; Cell Division; Cell Membrane; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Screening Assays, Antitumor; Fibroblasts; Growth Inhibitors; HeLa Cells; Humans; Leukemia L1210; Liver Neoplasms; Male; Mice; Mice, Inbred DBA; Neoplasm Proteins; Organometallic Compounds; Proteins; Tumor Cells, Cultured | 1998 |